Xencor reported $65.65M in Operating Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US USD 10.21B 1.08B
Alnylam Pharmaceuticals ALNY:US USD 598.93M 182.43M
Amgen AMGN:US USD 3.91B 504M
Arrowhead Research ARWR:US USD 105.32M 4.93M
AstraZeneca AZN:LN USD 9.74B 495M
Biogen BIIB:US USD 1.19B 1.45B
Bristol Myers Squibb BMY:US USD 8.75B 552M
Cytokinetics CYTK:US USD 133.2M 33.36M
GlaxoSmithKline GSK:LN GBP 6.64B 790M
Johnson & Johnson JNJ:US USD 17.97B 211M
Karyopharm Therapeutics KPTI:US USD 66.98M 15.6M
Macrogenics MGNX:US USD 66.69M 1.13M
Merk MRK:US USD 10.97B 1.31B
Novartis NOVN:VX USD 10.67B 183M
Pfizer PFE:US USD 13.23B 2.41B
Regeneron Pharmaceuticals REGN:US USD 1.71B 34.8M
Seattle Genetics SGEN:US USD 703.1M 72.49M
Xencor XNCR:US USD 65.65M 7.47M